CAMBRIDGE, Mass., Oct. 7, 2026 /PRNewswire/ -- Draper received up to $7.3 million other transaction award (OTA) from the Advanced Research Projects Agency for Health (ARPA-H) for Phase 1 of the agency's BioStabilization Systems (BoSS) program, which aims to develop new methods to produce,...
The coin-sized device can detect circulating cancer cells (CTCs) that break away from a tumor and travel through the bloodstream, potentially causing metastases.
Wisner Baum lawsuits allege manufacturers failed to warn patients and physicians about breast cancer risks associated with Risperdal, Invega and Zyprexa as a growing body of research links prolactin-elevating antipsychotics to increased breast cancer risk. LOS ANGELES, Oct. 7, 2026...
The bassist opened a GoFundMe to help cover medical costs and living expenses for himself and his family. Founding Death Angel Bassist Dennis Pepa Battling Stage 4 Cancer Langdon Hickman
Four New Endeavor Awards Unite Global Experts to Fight Cancer Key Takeaways Enabling International Collaboration: As funding uncertainties persist for multidisciplinary and international scientific partnerships, The Mark Foundation is purposefully connecting global teams to take on big...
NeOnc’s encouraging brain-cancer survival findings join 20206 developments from $RVMD, $MRNA, $MRK, $JNJ, $GMAB and $ABBV.
CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development
(PRP's) deep tumor control, fewer metastases, a less fibrotic microenvironment, and chemo re-sensitization...RAS inhibition does not directly address
Each year, some 15,000 Americans are diagnosed with glioblastoma, the deadliest form of brain cancer. Only 7% live more than five years but a new vaccine still in development could offer patients more time. NBC’s Anne Thompson reports for TODAY.
Enrollment completed in Part C of THIO-101 Phase 2 study; 65% of 2026 enrollment target reached in pivotal THIO-104 Phase 3 study
